EMA: First Adapted COVID-19 Vaccines Expected In September
Data Still Awaited On Valneva Vaccine & Molnupiravir
As work continues on vaccines adapted to tackle variants of SARS-CoV-2, the EU regulator says the decision-making on such products should take place at a global level.
